Shema Lab

Weizmann Institute

- · Israel

ERC-funded
Rate this labNo reviews yet — be the first.

Research focus

ERC Starting Grant · 2023

Comprehensive Platform for the Functional Characterization of Cancer Epigenetics and Diagnosis

Epigenetic regulation of gene expression- the mechanism responsible for establishing and maintaining cellular identities during development- is frequently deregulated in cancer. Our working hypothesis is that this deregulation confers upon cells phenotypic plasticity, resulting in intratumor heterogeneity, which is key to tumor development, metastasis, and drug resistance. In EpiCancer, we seek to provide the technological means to address fundamental issues concerning epigenetics in cancer. Namely, we intend to develop, apply, and validate single-cell and single-molecule epigenetic analysis methods that can parse the function of this network and its heterogeneity in human cancer, and…

From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.

Reviews

← All labs at Weizmann Institute